Varex Imaging Corporation (VREX)

NASDAQ: VREX · Real-Time Price · USD
10.09
-0.37 (-3.54%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Market Cap425.26M +25.9%
Revenue (ttm)857.50M +3.6%
Net Income-82.70M
EPS-1.99
Shares Out 42.15M
PE Ration/a
Forward PE10.62
Dividendn/a
Ex-Dividend Daten/a
Volume336,781
Open10.37
Previous Close10.46
Day's Range9.87 - 10.52
52-Week Range6.76 - 14.57
Beta0.90
AnalystsBuy
Price Target18.80 (+86.32%)
Earnings DateMay 7, 2026

About VREX

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products... [Read more]

Sector Healthcare
Founded 2016
Employees 2,450
Stock Exchange NASDAQ
Ticker Symbol VREX
Full Company Profile

Financial Performance

In fiscal year 2025, Varex Imaging's revenue was $844.60 million, an increase of 4.14% compared to the previous year's $811.00 million. Losses were -$70.30 million, 44.1% more than in 2024.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for VREX stock is "Buy." The 12-month stock price target is $18.8, which is an increase of 86.32% from the latest price.

Price Target
$18.8
(86.32% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Varex Imaging Transcript: Jefferies Global Healthcare Conference 2026

Management highlighted stable growth, new annual guidance, and three major growth drivers: India expansion, cargo inspection, and photon counting. AI and digital infrastructure are key enablers, while recent debt refinancing supports strategic flexibility.

2 days ago - Transcripts

Varex to Present at the Jefferies Global Healthcare Conference

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management ...

8 days ago - Business Wire

Varex Imaging reports Q2 adjusted EPS 21c, consensus 21c

Reports Q2 revenue $216M, consensus $216.92M. “Demand remained solid in the second quarter, with continued momentum across both our Medical and Industrial businesses driven by global CT, cargo systems...

4 weeks ago - TheFly

Varex Imaging sees Q3 adjusted EPS 15c-30c, consensus 22c

Sees Q3 revenue $210M-$225M, consensus $215.24M.

4 weeks ago - TheFly

Varex Imaging sees FY26 adjusted EPS 80c-$1.00, consensus 91c

Sees FY26 revenue $860M-$880M, consensus $872.38M.

4 weeks ago - TheFly

Varex Imaging Earnings Call Transcript: Q2 2026

Q2 revenue grew 1% year-over-year to $216 million, with strong CT and industrial performance and non-GAAP EPS of $0.21. Debt refinancing improved financial flexibility, and full-year 2026 revenue is guided at $860–$880 million. Inventory rose to support growth initiatives.

4 weeks ago - Transcripts

Varex Imaging Slides: Q2 2026

Varex Imaging has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on May 7, 2026.

4 weeks ago - Filings

Varex Imaging Earnings release: Q2 2026

Varex Imaging released its Q2 2026 earnings on May 7, 2026, summarizing the period's financial results.

4 weeks ago - Filings

Varex Imaging Quarterly report: Q2 2026

Varex Imaging has published its Q2 2026 quarterly earnings report on May 7, 2026.

4 weeks ago - Filings

Varex Announces Financial Results for Second Quarter Fiscal Year 2026

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter fiscal year 2026. Q2FY26 Summary Revenues $216 million ...

4 weeks ago - Business Wire

Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2026, following the clos...

6 weeks ago - Business Wire

Varex Imaging Transcript: Sidoti March Small-Cap Virtual Conference

X-ray imaging markets remain stable, with strong OEM relationships and growth in both medical and industrial segments. New factories in India and innovative photon counting technology are set to drive future revenue, while recent refinancing has improved financial flexibility.

2 months ago - Transcripts

Varex Imaging Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Business remains resilient amid geopolitical and tariff changes, with stable healthcare and industrial demand. China’s market has normalized, India facilities are ramping up for FY 2026-2028 growth, and photon counting technology is set to drive future margin expansion.

2 months ago - Transcripts

Varex Announces Successful Completion of Debt Refinancing

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has entered into a Credit and Guaranty Agreement (the “Credit Agreement”), dated as of March 13, 2026, whic...

2 months ago - Business Wire

Varex Management to Present in Upcoming Investor Conferences

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the following upcoming investor conferences. Oppenheimer's 36th Ann...

3 months ago - Business Wire

Varex Imaging Corporation to Redeem Its 7.875% Senior Secured Notes Due 2027

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) (the “Company” or “Varex”) today announced it has issued a notice of conditional full redemption of all of its outstanding 7.8...

3 months ago - Business Wire

Varex Imaging Transcript: AGM 2026

The meeting introduced board members, confirmed a quorum, and covered three proposals: board elections, executive compensation, and auditor ratification. All proposals passed, and stockholders could submit questions for live or later response.

4 months ago - Transcripts

Varex Imaging price target raised to $18 from $16 at B. Riley

B. Riley raised the firm’s price target on Varex Imaging (VREX) to $18 from $16 and keeps a Buy rating on the shares. The company’s fiscal Q1 beat was driven…

4 months ago - TheFly

Varex Imaging Earnings Call Transcript: Q1 2026

Q1 FY2026 revenue rose 5% year-over-year to $210 million, led by 17% growth in the industrial segment and stable medical performance. Non-GAAP EPS doubled to $0.19, and strong customer engagement and innovation are fueling a robust pipeline. Guidance for Q2 projects continued growth.

4 months ago - Transcripts

Varex Imaging Quarterly report: Q1 2026

Varex Imaging has published its Q1 2026 quarterly earnings report on February 10, 2026.

4 months ago - Filings

Varex Imaging Earnings release: Q1 2026

Varex Imaging released its Q1 2026 earnings on February 10, 2026, summarizing the period's financial results.

4 months ago - Filings

Varex Imaging Slides: Q1 2026

Varex Imaging has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on February 10, 2026.

4 months ago - Filings

Varex Imaging reports Q1 EPS 19c, consensus 13c

Reports Q1 revenue $210M consensus $207.8M. “We are pleased to report a solid start to fiscal 2026, with results toward the high-end of guidance. First quarter revenue of $210 million,…

4 months ago - TheFly

Varex Imaging sees Q2 EPS 15c-25c, consensus 19c

Sees Q2 revenue $210M-$225M, consensus $214.6M.

4 months ago - TheFly

Varex Announces Financial Results for First Quarter Fiscal Year 2026

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter fiscal year 2026. Q1FY26 Summary Revenues $210 million G...

4 months ago - Business Wire